Workflow
MannKind(MNKD)
icon
Search documents
MannKind(MNKD) - 2023 Q2 - Quarterly Report
2023-08-06 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 000-50865 MannKind Corporation (Exact name of registrant as specified in its charter) Delaware 13-3607736 (State or other jurisdiction of inc ...
MannKind(MNKD) - 2023 Q1 - Earnings Call Transcript
2023-05-10 01:29
MannKind Corporation (NASDAQ:MNKD) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Michael Castagna - CEO Steven Binder - CFO Conference Call Participants Oren Livnat - H.C. Wainwright Brandon Folkes - Cantor Fitzgerald Anish Nikhanj - RBC Capital Markets Thomas Smith - SVB Securities Steven Lichtman - Oppenheimer Anthony Petrone - Mizuho Operator Good afternoon. And welcome to the MannKind Corporation 2023 First Quarter Financial Results Earnings Call. As a reminder this call i ...
MannKind(MNKD) - 2023 Q1 - Quarterly Report
2023-05-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 000-50865 MannKind Corporation (Exact name of registrant as specified in its charter) Delaware 13-3607736 (State or other jurisdiction of in ...
MannKind (MNKD) Investor Presentation - Slideshow
2023-03-22 19:00
Oppenheimer 33rd Annual Healthcare Conference Michael Castagna, PharmD Chief Executive Officer March 14, 2023 NASDAQ: MNKD 1 © Copyright 2023. All rights reserved. MannKind Corporation. / 15 March 2023 Cautionary Statement Today's presentation includes forward-looking statements relating to the development, commercialization and benefits of our products and investigational product candidates, including AFREZZA®, that are subject to certain risks and uncertainties that could cause actual results to differ ma ...
MannKind(MNKD) - 2022 Q4 - Earnings Call Transcript
2023-02-24 14:38
MannKind Corporation (NASDAQ:MNKD) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ET Company Participants Michael Castagna - Chief Executive Officer Steven Binder - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Gregory Renza - RBC Mike Kratky - SVB Operator Good afternoon, and welcome to the MannKind Corporation 2022 Fourth Quarter and Full Year Financial Results Earnings Call. As a reminder, this call is being recorded on February 23, 2023 and will be available for ...
MannKind(MNKD) - 2022 Q4 - Annual Report
2023-02-22 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-50865 MannKind Corporation (Exact name of registrant as specified in its charter) Delaware 13-3607736 (State or other jurisdiction of incorpora ...
MannKind(MNKD) - 2022 Q3 - Earnings Call Transcript
2022-11-08 20:14
MannKind Corporation (NASDAQ:MNKD) Q3 2022 Results Conference Call November 8, 2022 9:00 AM ET Company Participants Michael Castagna - Chief Executive Officer Steven Binder - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Gregory Renza - RBC Capital Markets Robert Hazlett - BTIG Operator Good morning, and welcome to the MannKind Corporation Third Quarter 2022 Earnings Call. As a reminder, this call is being recorded on November 8, 2022, and will be available for play ...
MannKind(MNKD) - 2022 Q2 - Earnings Call Transcript
2022-08-10 01:47
MannKind Corp (NASDAQ:MNKD) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Michael Castagna - CEO & Director Steven Binder - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Thomas Smith - SVB Securities Operator Good afternoon, and welcome to the MannKind Corporation's Second Quarter 2022 Earnings Call. As a reminder, this call is being recorded on August 9, 2022, and will be available for playback on the MannKind Corporation website shortly after t ...